MET Rule 144 Notice: 269 Shares Proposed for Sale via Bernstein on 09/19/2025
Rhea-AI Filing Summary
MetLife, Inc. (MET) filed a Form 144 proposing the sale of 269 shares of Common Stock through Bernstein Institutional Services on 09/19/2025, with an aggregate market value of $21,269.83. The shares were acquired on 06/20/2014 from GOLDMAN SACHS and payment was made in cash on 06/25/2014. The filing reports 665,026,054 shares outstanding for the issuer. The document also discloses multiple recent sales by MetLife-related accounts in June and July 2025, including 547 shares sold on 06/20/2025 and 1,024 shares sold on 06/27/2025, showing routine plan and separate-account transactions.
Positive
- Clear compliance with Rule 144 disclosure requirements including acquisition, payment, broker, and proposed sale details
- Modest size of the proposed sale (269 shares, $21,269.83) relative to 665,026,054 shares outstanding, indicating immaterial impact on share count
Negative
- None.
Insights
TL;DR: Routine Rule 144 notice for a small proposed sale relative to total shares outstanding; not materially dilutive.
The filing notifies a proposed sale of 269 shares valued at $21,269.83 to be executed on 09/19/2025 via Bernstein Institutional Services. The shares were purchased in 2014 from GOLDMAN SACHS and paid in cash. Reported outstanding shares are 665,026,054, so this proposed transaction represents an immaterial fraction of the float. The filing also lists several executed sales by MetLife-related accounts in June and July 2025 consistent with plan or account rebalancing. For investors, this form is primarily a compliance disclosure rather than a material corporate event.
TL;DR: Filing appears to satisfy Rule 144 disclosure requirements; items disclosed are routine and procedurally compliant.
The notice includes required details: acquisition date (06/20/2014), seller